290 related articles for article (PubMed ID: 16998502)
1. Fanconi anaemia genes and susceptibility to cancer.
Mathew CG
Oncogene; 2006 Sep; 25(43):5875-84. PubMed ID: 16998502
[TBL] [Abstract][Full Text] [Related]
2. Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.
Cao AY; Huang J; Hu Z; Li WF; Ma ZL; Tang LL; Zhang B; Su FX; Zhou J; Di GH; Shen KW; Wu J; Lu JS; Luo JM; Yuan WT; Shen ZZ; Huang W; Shao ZM
Breast Cancer Res Treat; 2009 May; 115(1):51-5. PubMed ID: 18483852
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition.
Seal S; Barfoot R; Jayatilake H; Smith P; Renwick A; Bascombe L; McGuffog L; Evans DG; Eccles D; Easton DF; Stratton MR; Rahman N;
Cancer Res; 2003 Dec; 63(24):8596-9. PubMed ID: 14695169
[TBL] [Abstract][Full Text] [Related]
4. BRIP1 (BACH1) variants and familial breast cancer risk: a case-control study.
Frank B; Hemminki K; Meindl A; Wappenschmidt B; Sutter C; Kiechle M; Bugert P; Schmutzler RK; Bartram CR; Burwinkel B
BMC Cancer; 2007 May; 7():83. PubMed ID: 17504528
[TBL] [Abstract][Full Text] [Related]
5. The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia.
Levran O; Attwooll C; Henry RT; Milton KL; Neveling K; Rio P; Batish SD; Kalb R; Velleuer E; Barral S; Ott J; Petrini J; Schindler D; Hanenberg H; Auerbach AD
Nat Genet; 2005 Sep; 37(9):931-3. PubMed ID: 16116424
[TBL] [Abstract][Full Text] [Related]
6. Biallelic inactivation of BRCA2 in Fanconi anemia.
Howlett NG; Taniguchi T; Olson S; Cox B; Waisfisz Q; De Die-Smulders C; Persky N; Grompe M; Joenje H; Pals G; Ikeda H; Fox EA; D'Andrea AD
Science; 2002 Jul; 297(5581):606-9. PubMed ID: 12065746
[TBL] [Abstract][Full Text] [Related]
7. The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J.
Levitus M; Waisfisz Q; Godthelp BC; de Vries Y; Hussain S; Wiegant WW; Elghalbzouri-Maghrani E; Steltenpool J; Rooimans MA; Pals G; Arwert F; Mathew CG; Zdzienicka MZ; Hiom K; De Winter JP; Joenje H
Nat Genet; 2005 Sep; 37(9):934-5. PubMed ID: 16116423
[TBL] [Abstract][Full Text] [Related]
8. Fanconi anaemia and leukaemia - clinical and molecular aspects.
Tischkowitz M; Dokal I
Br J Haematol; 2004 Jul; 126(2):176-91. PubMed ID: 15238138
[TBL] [Abstract][Full Text] [Related]
9. Tetratricopeptide-motif-mediated interaction of FANCG with recombination proteins XRCC3 and BRCA2.
Hussain S; Wilson JB; Blom E; Thompson LH; Sung P; Gordon SM; Kupfer GM; Joenje H; Mathew CG; Jones NJ
DNA Repair (Amst); 2006 May; 5(5):629-40. PubMed ID: 16621732
[TBL] [Abstract][Full Text] [Related]
10. The Fanconi anaemia/BRCA pathway.
D'Andrea AD; Grompe M
Nat Rev Cancer; 2003 Jan; 3(1):23-34. PubMed ID: 12509764
[TBL] [Abstract][Full Text] [Related]
11. [Complex role of the FA proteins in providing genome stability].
Kluzek K; Zdzienicka MZ
Postepy Biochem; 2005; 51(4):387-94. PubMed ID: 16676573
[TBL] [Abstract][Full Text] [Related]
12. A cross-linker-sensitive myeloid leukemia cell line from a 2-year-old boy with severe Fanconi anemia and biallelic FANCD1/BRCA2 mutations.
Meyer S; Fergusson WD; Oostra AB; Medhurst AL; Waisfisz Q; de Winter JP; Chen F; Carr TF; Clayton-Smith J; Clancy T; Green M; Barber L; Eden OB; Will AM; Joenje H; Taylor GM
Genes Chromosomes Cancer; 2005 Apr; 42(4):404-15. PubMed ID: 15645491
[TBL] [Abstract][Full Text] [Related]
13. DNA repair pathways in clinical practice: lessons from pediatric cancer susceptibility syndromes.
Kennedy RD; D'Andrea AD
J Clin Oncol; 2006 Aug; 24(23):3799-808. PubMed ID: 16896009
[TBL] [Abstract][Full Text] [Related]
14. The Fanconi road to cancer.
D'Andrea AD
Genes Dev; 2003 Aug; 17(16):1933-6. PubMed ID: 12893780
[No Abstract] [Full Text] [Related]
15. [From gene to disease: Fanconi anemia].
Zwaan CM; Joenje H
Ned Tijdschr Geneeskd; 2003 Feb; 147(8):342-4. PubMed ID: 12661120
[TBL] [Abstract][Full Text] [Related]
16. A growing network of cancer-susceptibility genes.
Venkitaraman AR
N Engl J Med; 2003 May; 348(19):1917-9. PubMed ID: 12736286
[No Abstract] [Full Text] [Related]
17. Genetic reversion in an acute myelogenous leukemia cell line from a Fanconi anemia patient with biallelic mutations in BRCA2.
Ikeda H; Matsushita M; Waisfisz Q; Kinoshita A; Oostra AB; Nieuwint AW; De Winter JP; Hoatlin ME; Kawai Y; Sasaki MS; D'Andrea AD; Kawakami Y; Joenje H
Cancer Res; 2003 May; 63(10):2688-94. PubMed ID: 12750298
[TBL] [Abstract][Full Text] [Related]
18. Lack of large genomic deletions in BRIP1, PALB2, and FANCD2 genes in BRCA1/2 negative familial breast cancer.
Ameziane N; van den Ouweland AM; Adank MA; Vijzelaar RN; Errami A; Dorsman JC; Joenje H; Meijers-Heijboer H; Waisfisz Q
Breast Cancer Res Treat; 2009 Dec; 118(3):651-3. PubMed ID: 19504183
[No Abstract] [Full Text] [Related]
19. Downregulation of Fanconi anemia genes in sporadic head and neck squamous cell carcinoma.
Wreesmann VB; Estilo C; Eisele DW; Singh B; Wang SJ
ORL J Otorhinolaryngol Relat Spec; 2007; 69(4):218-25. PubMed ID: 17409780
[TBL] [Abstract][Full Text] [Related]
20. Biomedicine. D-Day for BRCA2.
Witt E; Ashworth A
Science; 2002 Jul; 297(5581):534. PubMed ID: 12065747
[No Abstract] [Full Text] [Related]
[Next] [New Search]
